- Home
- MAT vs VKTX Comparison
MAT vs VKTX Comparison
Compare MAT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAT | VKTX |
|---|---|---|
| Founded | 1945 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.1B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MAT | VKTX |
|---|---|---|
| Price | $14.91 | $29.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | $20.90 | ★ $95.86 |
| AVG Volume (30 Days) | ★ 4.3M | 2.2M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.24 | N/A |
| Revenue | ★ $5,347,623,000.00 | N/A |
| Revenue This Year | $5.92 | N/A |
| Revenue Next Year | $5.08 | N/A |
| P/E Ratio | $12.15 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.10 | $22.96 |
| 52 Week High | $22.48 | $43.15 |
Technical Indicators
Market Signals| Indicator | MAT | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 33.86 |
| Support Level | $14.75 | $23.08 |
| Resistance Level | $15.28 | $35.85 |
| Average True Range (ATR) | 0.48 | 1.56 |
| MACD | 0.09 | -0.53 |
| Stochastic Oscillator | 43.08 | 12.67 |
Price Performance
Historical ComparisonAbout MAT Mattel Inc.
Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the remainder stemming from international markets.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.